期刊文献+

我国四川、新疆两省人类免疫缺陷病毒感染者固定性伴侣暴露前预防用药接受意愿分析 被引量:3

Analysis of the willingness to accept pre-exposure prophylaxis among regular sex partners of HIV-infected individuals in Sichuan and Xinjiang provinces of China
下载PDF
导出
摘要 目的:了解我国四川、新疆两省人类免疫缺陷病毒(human immunodeficiency virus,HIV)感染者固定性伴侣(regular sexpartners,PAR)对暴露前预防用药(pre-exposure prophylaxis,PrEP)的接受意愿及其影响因素。方法:采用非随机抽样,对473位合格的研究对象进行面对面匿名问卷调查。采用χ2检验进行单因素分析,利用Logistic回归进行多因素分析。结果:我国四川、新疆两省的PAR对PrEP的知晓率不高,85.41%从未听说过PrEP,调查人员对PAR人群进行PrEP相关内容的讲解后,PrEP的接受意愿达到了80.34%。经Logistic回归分析,PAR人群PrEP接受意愿的影响因素包括民族(维吾尔/汉族:OR=2.471,P=0.009 3)、月收入水平(≤1 000元/1 001~3 000元:OR=2.046,P=0.018 4)、半年内是否与配偶发生过性行为(是/否:OR=2.263,P=0.019 2)、自认为从配偶处感染HIV的可能性(可能性一般/大:OR=0.485,P=0.065 1;可能性小/大:OR=0.447,P=0.027 3)、是否建议朋友使用PrEP(会/不会:OR=9.416,P〈0.000 1)、配偶查出感染HIV的时间(3年之内/1年内:OR=0.478,P=0.059 9;3年前/1年内:OR=0.374,P=0.009 4)。结论:我国四川、新疆两省的PAR对PrEP的知晓率低,接受意愿高,在今后的艾滋病干预工作中,应加大PrEP的宣传力度,提高其知晓率,进一步提高接受意愿。同时,不妨尝试在该人群中开展同伴教育,这可能是推广PrEP的有效方式。 Objective:To investigate the willingness to accept pre-exposure prophylaxis(PrEP) and its influencing factors among regular sex partners(PAR) of HIV-infected individuals in Sichuan and Xinjiang provinces.Methods:Face-to-face anonymous questionnaire was conducted for 473 qualified objects by non-randomly sampling method.χ2 test and Logistic regression were employed to do univariate analysis and multivariate analysis.Results:Awareness of PrEP among PAR was not high in Sichuan and Xinjiang provinces,85.41% had never heard of PrEP.80.34% PAR would like to accept PrEP after being taught on PrEP related knowledge by investigators.Logistic regression showed that the multiple influencing factors of the willingness to accept PrEP among PAR population were nationality(Uyghur/Han:OR=2.471,P=0.009 3),monthly income(≤1 000/1 001-3 000:OR=2.046,P=0.018 4),whether have sex with spouse within six months(yes/no:OR=2.263,P=0.019 2),self-awareness of the possibility to be infected with HIV from their spouses(medium possibility/great:OR=0.485,P=0.065 1;low possibility/great:OR=0.447,P=0.027 3),whether recommend friends to use PrEP(would/would not:OR=9.416,P0.000 1),the time when the spouse was diagnosed with HIV infection(within three years/one year: OR=0.478,P=0.059 9;three years ago/within one year:OR=0.374,P=0.009 4).Conclusions:Awareness of PrEP among PAR is not high in Sichuan and Xinjiang provinces,but the willingness to accept PrEP is high.Propaganda of PrEP in AIDS intervention should be strengthened in the future thus to improve the awareness of PrEP and the willingness to accept PrEP.Meanwhile,peer education could be possibly carried out among this population which might be an effective way to promote PrEP.
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2013年第4期395-400,共6页 Journal of Chongqing Medical University
基金 国家科技重大专项资助项目(编号:2008ZX10001-016)
关键词 人类免疫缺陷病毒 固定性伴侣 暴露前预防用药 接受意愿 human immunodeficiency virus regular sex partner pre-exposure prophylaxis willingness to accept
  • 相关文献

参考文献25

  • 1Naswa S,Marfatia Y S.Pre-exposure prophylaxis of HIV[J].Indian J Sex Transm Dis, 2011,32 ( 1 ) : 1-8.
  • 2Myers G M,Mayer K H.Oral preexposnre anti-HIV prophylaxis for high-risk U.S.populations :current considerations in light of new find- ings[J].AIDS Patient Care STDS, 2011,25 (2) : 63-71.
  • 3Clauson K A,Polen H H,Joseph S A,et al.Role of the pharmacist in pre-exposure chemoprophylaxis (PREP) therapy for HIV prevention [J].Pharmacy Practice, 2009,7 ( 1 ) : 11-18.
  • 4Van Griensven F,Thienkrua W,Sukwicha W,et al.Sex frequency and sex planning among men who have sex with men in Bangkok,Thai- land:implications for pre- and post-exposure prophylaxis against HIV infection[J].J Int AIDS Soc, 2010,13 : 13.
  • 5Garcia-lerma J G,Paxton L,Kilmarx P H,et al.Oral pre-exposure prophylaxis for HIV prevention[J].Trends Pharmacol Sci, 2010,31 (2) : 74-81.
  • 6Supervic V,Garcfa-lerma J G,Heneine W,et al.HIV,transmitted drug resistance, and the paradox of preexposure prophylaxis[J].Proc Natl Acad Sci USA,2010,107(27) : 12381-12386.
  • 7Liu A Y,Grant R M,Buehbinder S P.Pre-exposure prophylaxis for HIV : unproven promise and potential pitfalls [J].JAMA, 2006,296 ( 7 ) : 863-865.
  • 8Cohen J.HIV/AIDS.at last, vaginal gel scores victory against HIV [J].Seience, 2010,329 (5990) : 374-375.
  • 9Peterson L,Aylor D,Roddy R,et al.Tenofovir disoproxil fumarate for prevention of HIV infection in women:a phase 2,double-blind,ran- domized, placebo-controlled trial[J].PLOS Clin Trial, 2007,2 (5) : e27.
  • 10Grant R M,Lama J R,Anderston P L,et al.Pre-exposure Chemo- prophylaxis for HIV infection in men who have sex with men[J].N Engl J Med, 2010,363 : 2587-2599.

二级参考文献33

共引文献142

同被引文献55

  • 1Myers GM,Mayer KH.Oral preexposure anti-HIV prophylaxis for high-risk U.S. populations:current considerations in light of new findings[J].AIDS Patient Care STDS,2011,25(2):63-71.
  • 2Clauson KA,Polen HH,Joseph SA,et al.Role of the pharmacist in pre-exposure chemoprophylaxis(PrEP)therapy for HIV prevention[J].Pharm Pract(Granada),2009, 7(1): 11-18.
  • 3Griensven F,Thienkrua W,Sukwicha W,et al.Sex frequency and sex planning among nmn who have sex with in Bangkok,Thailand:implications for pre-and post-exposure prophylaxis against HIV infection[J].J Int AIDS Soc,2010(13):13.
  • 4Veloso VG,Mesquita F,Grinsztejn B.Pre-exposure prophylaxis for men and transgender women who have sex with men in Brazil:opportunities and challenges[J].J lnt AIDS Soc,2015,18(4 Suppl 3):20010.
  • 5Siemieniuk RA,Sivachandran N,Murphy P,et al.Transitioning to HIV pre-exposure prophylaxis(PrEP)from non-occupational post-exposure prophylaxis(nPEP)in a comprehensive HIV prevention clinic:a prospective cohort study[J].AIDS Patient Care STDS,2015,29(8):431-436.
  • 6Wilson EC,Jin H,Liu A,et al.Knowledge,indications and willingness to take pre-exposure prophylaxis among transwomen in San Francisco,2013[J].PLoS One, 2015,10(6): e0128971.
  • 7Mimiaga MJ,Case P,Johnson CV,et al.Precxposure antiretroviral prophylaxis attitudes in high-risk Boston area men who report having sex with men:limited knowledge and experience but potential for increased utilization after education [J].J Acquir Immune Defic Syndr,2009,50(1):77-83.
  • 8Liu AY,Kittredge PV,Vittinghoff E,et al. Limited knowledge and use of HIV post-and pre-exposure prophylaxis among gay and bisexual men[J].J Acquir Immune Defic Syndr, 2008,47 (2):241-247.
  • 9COHEN M S, CHEN Y Q, MCCAULEY M, et al. Prevention of HIV-1 infection with early antiretroviral therapy[J]. N Engl J Med, 2011, 365 (6): 493 -505.
  • 10Insight Start Study Group, LUNDGREN J D, BABIKER A G, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection E J ]. N Engl J Med, 2015, 373(9) : 795-807.

引证文献3

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部